Physician

Jamie Lynn Frey, MD

According to 2025 Medicare claims, Jamie Frey, MD (NPI: 1639391006) practices dermatology in the Peoria, IL market, with the plurality of this provider's patient population coming from Peoria, IL. This provider's primary affiliated billing organization is CENTRAL ILLINOIS DERMATOLOGY, S.C. (NPI: 1548358054; TIN: 371086127) and primary practice location at 61614-5068.

Frey's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,336 traditional Medicare patients, billed 10,358 HCPCS/CPT codes, and received $237,289 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,285 prescription claims across 477 beneficiaries totaling $197,939 in drug costs, led by Otezla (Apremilast). Open Payments data shows 7 records totaling $219. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $134,638 to $237,289. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $61,297 to $197,939. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$126K$251K2015 Medicare payment: $134,638 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $147,085 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $161,389 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $189,481 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $210,155 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $194,906 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $251,154 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $212,947 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $236,148 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $237,289 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159165,397$134,638
20161,0576,320$147,085
20171,2256,889$161,389
20181,3268,256$189,481
20191,3449,005$210,155
20201,2828,882$194,906
20211,3609,399$251,154
20221,2618,217$212,947
20231,3299,371$236,148
20241,33610,358$237,289

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$102K$204K2015 Drug cost: $61,297 (USD; Tot_Drug_Cst)2016 Drug cost: $67,184 (USD; Tot_Drug_Cst)2017 Drug cost: $70,122 (USD; Tot_Drug_Cst)2018 Drug cost: $203,627 (USD; Tot_Drug_Cst)2019 Drug cost: $122,142 (USD; Tot_Drug_Cst)2020 Drug cost: $141,788 (USD; Tot_Drug_Cst)2021 Drug cost: $191,745 (USD; Tot_Drug_Cst)2022 Drug cost: $139,974 (USD; Tot_Drug_Cst)2023 Drug cost: $146,516 (USD; Tot_Drug_Cst)2024 Drug cost: $197,939 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015378902$61,297
2016384902$67,184
20174061,031$70,122
20184291,071$203,627
20194441,086$122,142
20204501,183$141,788
20215061,400$191,745
20224471,234$139,974
20234861,269$146,516
20244771,285$197,939

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths661842$67
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more9201,153$52
11102Biopsy of related skin growth, first growth356396$50
17000Destruction of precancer skin growth, 1 growth7761,107$29
17003Destruction of precancer skin growth, 2-14 growths6245,967$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OtezlaApremilast11330$49,581
Dupixent PenDupilumab13364$49,133
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc2034,864$6,578
Betamethasone DipropionateBetamethasone Dipropionate802,060$2,862
KetoconazoleKetoconazole2175,824$2,510

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$219ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jamie Lynn Frey, MD?

Tedicare shows public-source Medicare data for Jamie Lynn Frey, MD (NPI 1639391006), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jamie Lynn Frey, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jamie Lynn Frey, MD?

Jamie Lynn Frey, MD is linked to CENTRAL ILLINOIS DERMATOLOGY, S.C. (billing NPI 1548358054) in the available physician profile data.

Does Jamie Lynn Frey, MD have Open Payments data?

Jamie Lynn Frey, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.